NurrOn Pharmaceuticals

Woburn, United States

NurrOn Pharmaceuticals operates as an innovative pharmaceutical company.

$1.7M raised

Nov 2024

Grant

Medical Pharmaceutical

Top Investors

Michael J. Fox Foundation Daewoong Pharmaceutical HanAll Biopharma

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NurrOn Pharmaceuticals

How much funding has NurrOn Pharmaceuticals raised?

NurrOn Pharmaceuticals has raised $1.7M in total funding. The most recent round was Grant. The last funding was announced in November 2024.

Who are NurrOn Pharmaceuticals's investors?

NurrOn Pharmaceuticals's investors include Michael J. Fox Foundation, Daewoong Pharmaceutical, HanAll Biopharma.

Where is NurrOn Pharmaceuticals headquartered?

NurrOn Pharmaceuticals is headquartered in Woburn, United States.

What does NurrOn Pharmaceuticals do?

NurrOn Pharmaceuticals operates as an innovative pharmaceutical company.

What stage is NurrOn Pharmaceuticals at?

NurrOn Pharmaceuticals is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 25, 2024.

MLA

"NurrOn Pharmaceuticals — Funding & Investors." VCBacked, November 25, 2024, https://www.vcbacked.co/company/nurron-pharmaceuticals. Accessed July 2, 2026.

APA

VCBacked. (2024). NurrOn Pharmaceuticals — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nurron-pharmaceuticals

Wikipedia (cite web)

{{cite web |title=NurrOn Pharmaceuticals — Funding & Investors |url=https://www.vcbacked.co/company/nurron-pharmaceuticals |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 25, 2024.